Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Shang-Tao Huang"'
Autor:
Cheng-Zu He, Zhi Zhang, Jian-Yan Lin, Ya-Qin Qin, Steven Mo, Shang-Tao Huang, Hong-Mian Li, Jian-Jun Liao
Publikováno v:
Aging (Albany NY)
Sorafenib has long been the only approved systemic therapy for advanced hepatocellular carcinoma (HCC), but most patients show primary or acquired drug resistance. In the present study, RNA was extracted from sorafenib-resistant and -sensitive clones
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e81c80e7da2e574f32d7112788f0e99b
http://europepmc.org/articles/PMC7762478
http://europepmc.org/articles/PMC7762478
